#AHA24 Journey: Interventional Treatments Your personalized Journey of Interventional Treatments science and exhibitors Inside, you’ll find: • Late-Breaking and Featured Science • Sessions dedicated to interventional treatment • Satellite Symposia • Learning Studios • Posters and Moderated Digital Posters • Interventional Treatments exhibitors
2 *Not a CE accredited session. See the Mobile Meeting Guide App for more details. MAIN EVENT LATE-BREAKING SCIENCE FEATURED SCIENCE Late-Breaking Science LBS.04 | From Intervention to Prevention: Advances in Coronary and Valvular Heart Disease Sunday, Nov. 17 | 8:00–9:15 a.m. Main Event I Main Event IN.ME.08 | Making Great Strides: Our Journey in the Treatment of Acute Myocardial Infarction Monday, Nov. 18 | 9:45–11:00 a.m. Main Event II TCT AT SESSIONS TCT.01 | Complex Coronary Revascularization: Case-Based Discussion* Saturday, Nov. 16 | 1:30–2:45 p.m. Heart Theater II, Science and Technology Hall TCT.02 | What’s the Latest in Interventional Cardiology? Clinical Trial and Science Update From TCT/ESC/AHA* Saturday, Nov. 16 | 3:15–4:30 p.m. Heart Theater II, Science and Technology Hall TCT.03 | Complex TAVR and Beyond: A Case-Based Discussion* Sunday, Nov. 17 | 9:45–11:00 a.m. Heart Theater II, Science and Technology Hall TCT.04 | Novel Mitral and Tricuspid Valve Therapies: Current Status and a Glimpse Into the Future* Sunday, Nov. 17 | 3:30–4:30 p.m. Heart Theater II, Science and Technology Hall TCT.05 | Challenging Decisions in ACS Management: A Case-Based Discussion* Monday, Nov. 18 | 9:45–11:00 a.m. Heart Theater II, Science and Technology Hall
*Not a CE accredited session. #AHA24 Journey: INTERVENTIONAL TREATMENTS 3 INTERVENTIONAL TREATMENTS Moderated Digital Poster Session* IN.MDP.01 | Advancements and Challenges in Percutaneous Coronary Interventions: Comparative Analyses, Predictive Indicators and Patient Outcomes Saturday, Nov. 16 | 9:30–10:55 a.m. Zone 4, Moderated Digital Poster 20, Science & Technology Hall Moderated Digital Poster Session* IN.MDP.02 | Cutting-Edge Critical Care in the Cath Lab: Addressing Shock and Cardiac Arrest Saturday, Nov. 16 | 9:30–10:55 a.m. Zone 4, Moderated Digital Poster 18, Science & Technology Hall Moderated Digital Poster Session* IN.MDP.03 | Medical Interventions for Coronary and Structural Heart Disease Saturday, Nov. 16 | 9:30–10:45 a.m. Zone 4, Moderated Digital Poster 21, Science & Technology Hall Cardiovascular Seminar IN.CVS.01 | How Soon Is Too Soon: A New Paradigm for the Preventive Management of Aortic Stenosis Saturday, Nov. 16 | 9:45–11:00 a.m. N426C Abstract Poster Session* IN.APS.02 | Managing the Rarest of Cases: Super Hero Interventionalist to the Rescue! Saturday, Nov. 16 | 10:30–11:30 a.m. Zone 4, Science & Technology Hall Abstract Poster Session* IN.APS.01 | Novel Insights in Coronary Intervention Saturday, Nov. 16 | 10:30–11:30 a.m. Zone 4, Science & Technology Hall Abstract Poster Session* IN.APS.03 | Vascular and Microvascular Considerations for Coronary Intervention Saturday, Nov. 16 | 10:30–11:30 a.m. Zone 4, Science & Technology Hall Moderated Digital Poster Session* IN.MDP.04 | Challenges and Innovations in Coronary Interventions: Bifurcation Disease, Atherectomy and CTO Abstracts Saturday, Nov. 16 | 11:10 a.m.–12:35 p.m. Zone 4, Moderated Digital Poster 21, Science & Technology Hall Moderated Digital Poster Session* IN.MDP.05 | Exploring Advances in Coronary Physiology: Insights on the Latest in Clinical Research Saturday, Nov. 16 | 11:10 a.m.–12:35 p.m. Zone 4, Moderated Digital Poster 18, Science & Technology Hall Moderated Digital Poster Session* IN.MDP.06 | Peripheral Interventions...: Venturing Beyond the Coronaries Saturday, Nov. 16 | 11:10 a.m.–12:35 p.m. Zone 4, Moderated Digital Poster 20, Science & Technology Hall Moderated Digital Poster Session* IN.MDP.07 | Common Complications After TAVR: A Dive Into the Data Saturday, Nov. 16 | 12:50–2:15 p.m. Zone 4, Moderated Digital Poster 20, Science & Technology Hall Moderated Digital Poster Session* IN.MDP.08 | Deep Dive Into Transcatheter Mitral Valve Therapies Saturday, Nov. 16 | 12:50–2:15 p.m. Zone 4, Moderated Digital Poster 21, Science & Technology Hall Cardiovascular Seminar IN.CVS.02 | Heartfelt Innovations: Interventional Therapeutics for the Management of Acute and Chronic Heart Failure Saturday, Nov. 16 | 1:30–2:45 p.m. S401D Abstract Poster Session* IN.APS.05 | All Things Mitral! Saturday, Nov. 16 | 2:00–3:00 p.m. Zone 4, Science & Technology Hall
*Not a CE accredited session. 4 Abstract Poster Session* IN.APS.04 | TAVR Potpourri Saturday, Nov. 16 | 2:00–3:00 p.m. Zone 4, Science & Technology Hall Moderated Digital Poster Session* IN.MDP.09 | Aortic Stenosis: Treatment Strategies and Technical Considerations Saturday, Nov. 16 | 2:50–4:15 p.m. Zone 4, Moderated Digital Poster 20, Science & Technology Hall Moderated Digital Poster Session* IN.MDP.10 | Beyond the Coronary Arteries and Valves...Innovations in Left Atrial Occlusion and Pulmonary Embolism Management Saturday, Nov. 16 | 2:50–4:15 p.m. Zone 4, Moderated Digital Poster 21, Science & Technology Hall Cardiovascular Seminar IN.CVS.03 | Circulation Cardiovascular Interventions 2023-2024 Editors’ Picks: The Best and What’s Next Sunday, Nov. 17 | 8:00–9:15 a.m. S103D Cardiovascular Seminar IN.CVS.04 | Too Far Gone? Revascularization of Multivessel CAD in Severe Cardiomyopathy Sunday, Nov. 17 | 9:45–11:00 a.m. N140 Abstract Poster Session* IN.APS.06 | Interventional Insights Sunday, Nov. 17 | 11:30 a.m.–12:30 p.m. Zone 4, Science & Technology Hall Abstract Poster Session* IN.APS.07 | TAVR Outcomes in Specific Subgroups Sunday, Nov. 17 | 3:15–4:15 p.m. Zone 4, Science & Technology Hall Abstract Poster Session* IN.APS.08 | TAVR: Which Valve, Which Patient? Sunday, Nov. 17 | 3:15–4:15 p.m. Zone 4, Science & Technology Hall Abstract Oral Session IN.AOS.01 | Hot Topics in Valvular Heart Disease Sunday, Nov. 17 | 3:30–4:45 p.m. S105D Joint Session IN.JS.01 | INOCA: Recent Advancement in the Diagnosis and Treatment (AHA Joint Sessions With Japanese Society of Cardiology) Sunday, Nov. 17 | 3:30–4:45 p.m. N426C Cardiovascular Seminar IN.CVS.05 | MAC Attack: Deep Dive Into Multidisciplinary Perspectives on Management of Mitral Annular Calcium Monday, Nov. 18 | 8:00–9:15 a.m. N229 Joint Session IN.JS.02 | Practical Approaches to Optimal Acute Coronary Syndrome Management: UAE’s Insights and Strategies (AHA Joint Session With the Emirates Cardiac Society) Monday, Nov. 18 | 8:00–9:15 a.m. N136 Abstract Poster Session* IN.APS.10 | Deep Dive Into Drug-Coated Balloons Monday, Nov. 18 | 10:30–11:30 a.m. Zone 4, Science & Technology Hall Abstract Poster Session* IN.APS.09 | Making it Right: Interventions for the Tricuspid Valve and Right Heart Monday, Nov. 18 | 10:30–11:30 a.m. Zone 4, Science & Technology Hall Abstract Oral Session IN.AOS.02 | Approaching the Fork in the Road: Strategies and Outcomes for Managing Bifurcation Lesions Monday, Nov. 18 | 1:30–2:45 p.m. N426C
#AHA24 Journey: INTERVENTIONAL TREATMENTS 5 *Not a CE accredited session. Abstract Poster Session* IN.APS.12 | Complications of Coronary and Structural Intervention Monday, Nov. 18 | 1:30–2:30 p.m. Zone 4, Science & Technology Hall Abstract Poster Session* IN.APS.11 | What’s Hot in Percutaneous Coronary Intervention? Monday, Nov. 18 | 1:30–2:30 p.m. Zone 4, Science & Technology Hall SYMPOSIA Early or Earlier? Optimal Timing for Valve Replacement in Aortic Stenosis Friday, Nov. 15 | 6-7:30 p.m. JW Marriott Chicago, Grand Ballroom, Second Floor SPONSOR: Haymarket Medical Education SUPPORTER: Edwards Lifesciences Register online at www.myCME.com/EarlyTAVR2024 This event is not part of the official Scientific Sessions Conference 2024 as planned by the American Heart Association Committee on Scientific Sessions Programming. DON’T MISS Presidential Session and Conner Lecture Sunday, Nov. 17 | 1:30–3:00 p.m. Main Event I Lewis A. Conner Presidential Lecture Keith Churchwell, MD, FACC, FACP, FAHA New Haven, Connecticut Chairman’s Award Robert A. Harrington, MD, FAHA New York, New York Eugene Braunwald Academic Mentorship Award Jane W. Newburger, MD, MPH Boston, Massachusetts Research Achievement Award Roderic I. Pettigrew, PhD, MD Houston, Texas Basic Research Award Lauren Sansing, MD, MS, FAHA New Haven, Connecticut Clinical Research Award Herman A. Taylor, Jr., MD, MPH, FAHA, FACC Atlanta, Georgia Population Research Award Virginia J. Howard, PhD Birmingham, Alabama Journey: Interventional Treatments View online. Please check the Online Program Planner for the latest program content.
*Not a CE accredited session. 6 2502 2512 Posters Zone 2 Moderated Digital Posters 6-11 201 Public Service 1 2 3 12 13 14 320 Puppy Snuggles Supported by Sanofi 323 324 326 327 328 331 423 424 426 427 521 Bayer 526 Bridgebio 531 Eli Lilly and Company 537 Daiichi Sankyo, Inc. 541 Getting to the Heart of Stroke 702 Duke Clinical Research Institute 706 708 710 712 BMS/ Pfizer 716 Mayo Clinic 902 Bristol Myers Squibb 909 Intermountain Health 914 917 Merck & Co., Inc. 921 1109 Boehringer Ingelheim/Lilly Commercial 1112 New Amsterdam Pharma 1115 Pfizer, Inc. 1119 ZOLL Medical Corporation 1123 Medtronic 1302 Novartis Pharmaceuticals Corporation 1308 Novartis Pharmaceuticals Corporation 1312 Cytokinetics 1316 AstraZeneca 1322 Merck & Co., Inc. 1702 Esperion Therapeutics 1705 Idorsia Pharmaceuticals US Inc. 1708 1710 1714 1717 Arrowhead Pharmaceuticals 1720 1721 1808 1809 1820 1821 1902 Johnson & Johnson 1912 Amgen 1920 1921 1924 Amarin Pharma, Inc. 2020 2021 2022 2109 Silence Therapeutics 2120 2122 2220 2224 Kiniksa Pharmaceuticals 2302 Novo Nordisk, Inc. 2308 2309 2310 2312 2313 2315 2316 2318 Amgen 2321 Alnylam Pharmaceuticals 2408 2409 2410 2412 2413 2415 AtriCure 2514 BMS/J&J Alliance 2517 American College of Cardiology 2520 Viatris 2526 2527 2528 2531 2532 2533 2534 2712 2713 2714 2715 2717 2718 2719 2720 2721 2739 Lexicon Pharmaceuticals, Inc. 2812 2813 2814 2815 2817 2818 2819 2820 2821 2222 806 808 809 Posters Zone 1 Moderated Digital Posters 1-5 CardioTalk Theater I Eli Lilly and Company FEC UP UP Best of Specialty Conferences Posters to.5 ENTRANCE Poster Attendant Booth GRAND CONCOURSE EXIT EMERGENCY EMERGENCY EXIT Global Quality Showcase HeartQuarters FAHA Lounge Heart Theater I Abstracts on USB Supported by Lexicon NT I Exhibit Hall Concierge Desk B1 B2 B5 B6 B9 B10 B13 B14 B39 B40 B41 B42 Publisher's Row 2939 2942 3042 3139 3140 3141 3142 3239 3240 3241 3242 1909 2009 2010 INTERVENTIONAL TREATMENT EXHIBITORS (highlighted in yellow) Science & Technology Hall Hours Saturday, Nov. 16 9 a.m.-4:30 p.m. Sunday, Nov. 17 9 a.m.-4:30 p.m. Monday, Nov. 18 9 a.m.-3 p.m.
*Not a CE accredited session. #AHA24 Journey: INTERVENTIONAL TREATMENTS 7 Posters Zone 4 Moderated Digital Posters 17-23 3468 Posters Zone 3 Moderated Digital Posters 12-16 4 5 6 Simulation Zone 8 9 10 11 3072 AHA Scholars’ Posters Supporting Undergraduate Research Experiences (S.U.R.E.) Program 15 16 2542 Novo Nordisk, Inc. 2550 CardioTalk Theater II 2754 Lp(a) Testing Supported by Novartis Pharmaceuticals Corporation HEART HUB HIPods 1-3 HIPods 4-6 Health Innovation Pavilion STAGE UP UP UP EMERGENCY EXIT EMERGENCY EXIT EMERGENCY EXIT Charging Lounge Supported by Eli Lilly and Company Member Lounge Learning Studio I Learning Studio II Heart Theater II 7 B3 B4 B7 B8 B11 B12 B15 B16 B17 B18 B19 B20 B21 B22 B23 B24 B25 B27 B28 B31 B34 Exhibitor Lounge/ Sales Office B35 Business Suites B26 B30 B36 B48 B45 B41 B42 B47 B46 2943 2945 Wolters Kluwer 2951 2952 3043 3051 3052 3143 3145 3151 3152 3243 3251 3252 2654 2557 Rocket Pharmaceuticals, Inc. Dedicated IT 2554 • Biobeat • Cardiac Insight Inc. Agepha Pharma FZ-LLC . . . . . . . . . . . 2220 Amarin Pharma, Inc. . . . . . . . . . . . . . 1924 American College of Cardiology . . . . . . . . 2517 Amgen.................1912,2318 AnkrHealth.................2533 AskBio . . . . . . . . . . . . . . . . . . . .2312 BillingsClinic. . . . . . . . . . . . . . . . .424 Biobeat . . . . . . . . . Health Innovation Pavilion BrukerBioSpin. . . . . . . . . . . . . . . .2309 Cardiac Insight Inc. . . . Health Innovation Pavilion Edwards Lifesciences . . . . . . . . . . . . . 1921 Esperion Therapeutics . . . . . . . . . . . . .1702 Foresee Pharmaceuticals . . . . . . . . . . . 2316 FUJIFILM VisualSonics . . . . . . . . . . . . .1708 GenomadixInc.. . . . . . . . . . . . . . . .2412 HeartBeam,Inc. . . . . . . . . . . . . . . .2313 HeartFlow..................1909 Inspire Medical Systems, Inc. . . . . . . . . . 2408 Intellia Therapeutics . . . . . . . . . . . . . 2534 Intermountain Health . . . . . . . . . . . . . 909 JAMANetwork................2943 Kiniksa Pharmaceuticals . . . . . . . . . . . 2224 Kusmo . . . . . . . . . . . . . . . . . . . . 710 MayoClinic..................716 McFarlandClinic. . . . . . . . . . . . . . . 423 Medtronic . . . . . . . . . . . . . . . . . . 1123 Mineralys Therapuetics, Inc. . . . . . . . . . . 427 New Amsterdam Pharma . . . . . . . . . . . 1112 Novartis Pharmaceuticals Corporation . . . . . . . . . .1302 Novo Nordisk Inc. . . . . . . . . . . . .2302, 2542 Pfizer Inc. . . . . . . . . . . . . . . . . . . .1115 PPD™, part of Thermo Fisher Scientific . . . . . 1720 Silence Therapeutics . . . . . . . . . . . . . 2109 VectorBuilderInc. . . . . . . . . . . . . . . . 808 WoltersKluwer............... 2945 ZOLL Medical Corporation . . . . . . . . . . . 1119
Paid Advertisement Reduce the risk of ischemic and bleeding adverse events. Connect with at booth 2412.
RkJQdWJsaXNoZXIy MjI2NjI=